Can Early Transplant Be Used for Patients with Low-Risk MDS?

A roundtable discussion, moderated by Guillermo Garcia-Manero, MD, Blood Cancers Today Associate Editor, of the University of Texas MD Anderson Cancer Center, focused on the latest data in the treatment of low-risk myelodysplastic syndromes. Dr. Garcia-Manero was joined by Jamie Koprivnikar, MD; George Yaghmour, MD; and Sangeetha Venugopal, MD.
In the next segment of the roundtable series, the panel talks about the use of transplant for patients with low-risk myelodysplastic syndromes.